Utrecht, Netherlands

Merus B.v.


USPTO Granted Patents = 8



Trademarks = 2

Forward Citations = 298

Loading Chart...
Loading Chart...

31 inventors (with patents filed for the assignee):

goldMedal Ton Logtenberg (8 out of 56 patents)

silverMedal Linda Johanna Aleida Hendriks (3 out of 10 patents)

bronzeMedal Abraham Bout (3 out of 55 patents)

4 Cornelis Adriaan De Kruif (3 out of 49 patents)

5 Hendricus Renerus Jacobus Mattheus Hoogenboom (2 out of 28 patents)

6 Patrick H C Van Berkel (2 out of 3 patents)

7 Ronald Hendrik Peter Brus (2 out of 6 patents)

8 Ronald Hendrik Brus (1 out of 3 patents)

9 Patricius H C Van Berkel (1 out of 2 patents)

10 Mark Throsby (46 patents)

11 Patricius Hendrikus Van Berkel (1 patent)

12 Hendricus Renerus Hoogenboom (0 patent)

13 Erwin Houtzager (0 patent)

14 Rui Daniel Pinto (0 patent)

15 Patrick Hendrikus Cornelis Van Berkel (0 patent)


8 patents:

Merus B.V. is a clinical-stage immuno-oncology company developing innovative full-length bispecific antibody therapeutics, referred to as Biclonics. Our lead product candidate, zenocutuzumab, is currently being evaluated in a Phase 1/2 clinical trial for various types of solid tumors. Merus' unique Biclonics platform allows for the precise targeting of multiple pathways to enhance tumor cell killing and potentially overcome treatment resistance.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

8 Patents

#18 in Utrecht

#732 in Netherlands

...
Utrecht, Netherlands
Forward Citations = 298

31 inventors:

Please report any incorrect information to support@idiyas.com
Loading…